Wealthcare Advisory Partners’s Humana HUM Stock Holding History

Wealthcare Advisory Partners’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-141	Closed	-$59K	–	1135
2021 Q1	$59K	Buy	+141	New	+$56.3K	﹤0.01%	827

Other funds holding HUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wealthcare Advisory Partners's HUM Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of Humana (HUM) in Q2 2021, closing a stake of 141 shares — an estimated $59K sold.

Wealthcare Advisory Partners first reported a position in HUM in Q1 2021 and held it in 1 quarter. The position peaked at $59K in Q1 2021. 887 funds tracked by Wall St. Rank hold HUM as of Q2 2021.

Wealthcare Advisory Partners reported no remaining Humana position as of Q2 2021 after selling out during the quarter.
Wealthcare Advisory Partners sold 141 Humana shares in Q2 2021, an estimated $59K.
Wealthcare Advisory Partners first reported a position in Humana in Q1 2021 and held it in 1 quarter.
Wealthcare Advisory Partners's Humana position peaked at $59K in Q1 2021.
887 funds tracked by Wall St. Rank held Humana as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.